Other types of follicular lymphoma, extranodal and solid organ sites
ICD-10 C82.89 is a billable code used to indicate a diagnosis of other types of follicular lymphoma, extranodal and solid organ sites.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. C82.89 specifically refers to cases of follicular lymphoma that occur in extranodal sites or solid organs, which can include the gastrointestinal tract, skin, or other organs outside of lymph nodes. This subtype may present with varied clinical features and can be associated with more aggressive behavior compared to typical nodal follicular lymphoma. Patients may experience B-symptoms such as fever, night sweats, and weight loss, which can indicate more advanced disease. Staging of follicular lymphoma typically follows the Ann Arbor classification, which assesses the extent of disease spread. Treatment protocols may include watchful waiting for indolent cases, chemotherapy, immunotherapy, or targeted therapies, depending on the stage and symptoms. The prognosis can vary significantly based on the specific characteristics of the lymphoma and the patient's overall health.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Diagnosis of follicular lymphoma in patients presenting with B-symptoms or incidental findings on imaging.
Ensure accurate staging and documentation of extranodal sites to support coding.
Histological confirmation of lymphoma subtype and extranodal involvement.
Biopsy results indicating follicular lymphoma with extranodal characteristics.
Pathology reports must clearly state the type of lymphoma and any extranodal sites involved.
Used when a biopsy is performed to confirm the diagnosis of follicular lymphoma.
Pathology report must include details of the lymphoma type and staging.
Pathologists should ensure clear documentation of the lymphoma subtype.
Treatment options may include chemotherapy, immunotherapy, targeted therapies, or watchful waiting, depending on the stage and symptoms of the lymphoma.
